BTK Isoforms p80 and p65 Are Expressed in Head and Neck Squamous Cell Carcinoma (HNSCC) and Involved in Tumor Progression
Article in Cancers (January 2023)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
BTK is a Prognostic Biomarker for Multiple Human Tumors
Preprint in Research Square (November 2022)
Bruton’s Tyrosine Kinase Inhibitors: The Next Frontier of B-Cell-Targeted Therapies for Cancer, Autoimmune Disorders, and Multiple Sclerosis
Article in Journal of Clinical Medicine (October 2022)